Jeffrey M Leiden - Net Worth and Insider Trading

Jeffrey M Leiden Net Worth

The estimated net worth of Jeffrey M Leiden is at least $53 Million dollars as of 2024-11-06. Jeffrey M Leiden is the President and COO of Abbott Laboratories and owns about 401,882 shares of Abbott Laboratories (ABT) stock worth over $47 Million. Jeffrey M Leiden is the Executive Chairman of Vertex Pharmaceuticals Inc and owns about 10,434 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $5 Million. Jeffrey M Leiden is also the Director of Quest Diagnostics Inc and owns about 6,000 shares of Quest Diagnostics Inc (DGX) stock worth over $924,600. Details can be seen in Jeffrey M Leiden's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey M Leiden has not made any transactions after 2024-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jeffrey M Leiden

To

Jeffrey M Leiden Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey M Leiden owns 5 companies in total, including Vertex Pharmaceuticals Inc (VRTX) , Quest Diagnostics Inc (DGX) , and Abbott Laboratories (ABT) among others .

Click here to see the complete history of Jeffrey M Leiden’s form 4 insider trades.

Insider Ownership Summary of Jeffrey M Leiden

Ticker Comapny Transaction Date Type of Owner
VRTX Vertex Pharmaceuticals Inc 2024-08-30 director
DGX Quest Diagnostics Inc 2018-05-29 director
ABT Abbott Laboratories 2006-02-17 director & President & COO
LIMIT LIMIT 2021-03-17 director
LIMIT LIMIT 2021-03-17 director

Jeffrey M Leiden Latest Holdings Summary

Jeffrey M Leiden currently owns a total of 3 stocks. Among these stocks, Jeffrey M Leiden owns 401,882 shares of Abbott Laboratories (ABT) as of February 17, 2006, with a value of $47 Million and a weighting of 88.51%. Jeffrey M Leiden owns 10,434 shares of Vertex Pharmaceuticals Inc (VRTX) as of August 30, 2024, with a value of $5 Million and a weighting of 9.76%. Jeffrey M Leiden also owns 6,000 shares of Quest Diagnostics Inc (DGX) as of May 29, 2018, with a value of $924,600 and a weighting of 1.73%.

Latest Holdings of Jeffrey M Leiden

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABT Abbott Laboratories 2006-02-17 401,882 117.73 47,313,568
VRTX Vertex Pharmaceuticals Inc 2024-08-30 10,434 499.88 5,215,748
DGX Quest Diagnostics Inc 2018-05-29 6,000 154.10 924,600

Holding Weightings of Jeffrey M Leiden


Jeffrey M Leiden Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey M Leiden has made a total of 0 transactions in Abbott Laboratories (ABT) over the past 5 years. The most-recent trade in Abbott Laboratories is the sale of 2,000 shares on February 17, 2006, which brought Jeffrey M Leiden around $88,820.

According to the SEC Form 4 filings, Jeffrey M Leiden has made a total of 19 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 3,784 shares on August 30, 2024, which brought Jeffrey M Leiden around $2 Million.

According to the SEC Form 4 filings, Jeffrey M Leiden has made a total of 0 transactions in Quest Diagnostics Inc (DGX) over the past 5 years. The most-recent trade in Quest Diagnostics Inc is the sale of 1,644 shares on May 29, 2018, which brought Jeffrey M Leiden around $173,623.

Insider Trading History of Jeffrey M Leiden

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey M Leiden Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey M Leiden's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey M Leiden is -10.23%. GuruFocus also compares Jeffrey M Leiden's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey M Leiden within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey M Leiden's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey M Leiden

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.2 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.25 LIMIT LIMIT LIMIT LIMIT LIMIT

Jeffrey M Leiden Ownership Network

Ownership Network List of Jeffrey M Leiden

No Data

Ownership Network Relation of Jeffrey M Leiden

Insider Network Chart

Jeffrey M Leiden Owned Company Details

What does Vertex Pharmaceuticals Inc do?

Who are the key executives at Vertex Pharmaceuticals Inc?

Jeffrey M Leiden is the director of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP and Chief Legal Officer Jonathan Biller , EVP and CMO Carmen Bozic , and director & CEO & President Reshma Kewalramani .

Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary

Over the past 18 months, Jeffrey M Leiden made 7 insider transaction in Vertex Pharmaceuticals Inc (VRTX) with a net sale of 51,156. Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 47,585 shares made by Carmen Bozic , a net sale of 16,533 shares made by Ourania Tatsis , and a net sale of 77,232 shares made by Reshma Kewalramani .

In summary, during the past 3 months, insiders sold 9,001 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 9,001 shares. During the past 18 months, 345,317 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 345,317 shares.

Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vertex Pharmaceuticals Inc Insider Transactions

No Available Data

Jeffrey M Leiden Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey M Leiden. You might contact Jeffrey M Leiden via mailing address: 15 N Beach Road, Hobe Sound Fl 33455.